The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has started a referral for modified release oral opioids (morphine, fentanyl, oxycodone and hydromorphone) due to concerns on their dissolution and their sensitivity and interaction with alcohol, which may cause dose dumping and potential overdose.